1.1.1.189	17beta-estradiol	equimolar to substrate inhibits 80% of enzyme activity	745	
1.1.1.189	17beta-estradiol	-	745	
1.1.1.189	17beta-estradiol	equimolar to substrate inhibits 49% of enzyme activity	745	
1.1.1.189	5,5'-dithiobis(2-nitrobenzoate)	complete inhibition at 1 mM concentration	303	
1.1.1.189	aspirin	equimolar to substrate inhibits 65% of enzyme activity	3100	
1.1.1.189	cortisol	-	919	
1.1.1.189	cortisol	equimolar to substrate inhibits 55% of enzyme activity	919	
1.1.1.189	Cu2+	5 mM concentration	19	
1.1.1.189	FAD	5 mM concentration	20	
1.1.1.189	Fentiazac	non competitive	44127	
1.1.1.189	indomethacin	non competitive	546	
1.1.1.189	indomethacin	equimolar to substrate inhibits 81% of enzyme activity	546	
1.1.1.189	interferon tau	recombinant ovine interferon tau inhibits 25% prostaglandin E2 and prostaglandin F2alpha production at a concentration of 1 ng per ml	21620	
1.1.1.189	lonazolac	equimolar to substrate inhibits 78% of enzyme activity	106483	
1.1.1.189	additional information	no effect: Mg2+, Ca2+, EDTA, EGTA, cAMP and cGMP	2	
1.1.1.189	NAD+	5 mM concentration 60% inhibition, competitive	7	
1.1.1.189	NADP+	5 mM concentration 60% inhibition, non-competitive	10	
1.1.1.189	nitric oxide	inhibition e.g. by NOC-18, a NO donor	662	
1.1.1.189	p-chloromercuribenzoate	complete inhibition at 1 mM concentration	43	
1.1.1.189	palmitic acid	inhibits enzyme in dose-dependent manner	535	
1.1.1.189	progesterone	non competitive	286	
1.1.1.189	progesterone	equimolar to substrate inhibits 69% of enzyme activity	286	
1.1.1.189	prostaglandin E2	inhibits the reduction of 20alpha-hydroxy-pregn-4-en-3-one to progesterone competitively	913	
1.1.1.189	Substance P	-	1259	
1.1.1.189	vitamin D3	equimolar to substrate inhibits 38% of enzyme activity	2767